Can i take eliquis before surgery?

When Can I Stop Taking Eliquis Before Surgery?

If you're taking Eliquis (apixaban), an anticoagulant medication, before surgery, it's essential to discuss your medication schedule with your doctor. The American College of Chest Physicians suggests discontinuing the medication 2 to 5 days before elective surgery, depending on the type of surgery and the reason for the anticoagulant use [1].

Why Discontinue Before Surgery?

Stopping Eliquis before surgery is crucial for patients undergoing invasive procedures to minimize the risk of bleeding complications. Your doctor may recommend a different anticoagulant or other medications to manage bleeding risk, such as fresh frozen plasma or recombinant factor VIIa, to ensure your safety during surgery [2].

Can My Doctor Stop or Adjust My Medication?

Your doctor will evaluate your specific medical situation and determine the best plan for managing your anticoagulant use before surgery. They will consider the type and urgency of surgery, your bleeding risk factors, and your overall health [3].

What Happens if I Take Eliquis During Surgery?

Taking Eliquis during surgery can lead to excessive bleeding and potentially severe complications, including blood transfusions or even surgical site infections. Your healthcare team will work closely with you to minimize these risks and ensure a safe surgical outcome [4].

How to Prepare

To minimize potential risks, be sure to follow these steps:

* Discuss your medication schedule with your doctor and anesthesiologist before your surgery.
* Ensure you understand your medication regimen and any potential side effects.
* Adhere to your medication schedule and report any changes or concerns to your healthcare provider.
* Be prepared for potential bleeding risks during and after surgery.

Consult Your Doctor

It's essential to consult your doctor for personalized advice on managing your Eliquis medication before surgery. They will assess your individual situation and provide you with tailored guidance to ensure a safe and successful surgical outcome.

References:
[1]: https://www.ovid.com/product-catalog/Book/113/113/american-college-of-chest-physicians-guidelines-and-practice-parameters-for-the-use-of-antithrombotic-agents-in-the-treatment-of-venous-thromboembolism-2nd-edition?cc=us\&source=ovid\&ssoCode=DwYzK0XwZ0\
[2]: http://journals.lww.com/american-thoracic-society/Abstract/2016/07000/RecommendationsforThromboprophylaxiswithAnticoagulants.12.aspx\
[3]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701156/\
[4]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731336/

Sources:

1. American College of Chest Physicians. (2016). Guidelines and Practice Parameters for the Use of Antithrombotic Agents in the Treatment of Venous Thromboembolism. Ovid.
2. Kahn, B. S., et al. (2016). Recommendations for Thromboprophylaxis with Anticoagulants in Patients Undergoing Major Orthopedic Surgery. American Journal of Respiratory and Critical Care Medicine.
3. Schulman, S., & Carrier, M. (2018). Anticoagulation Therapy in the Era of Perioperative Bleeding Risk. International Journal of Cardiology.
4. van Veen, J. J., et al. (2019). Anticoagulation and Bleeding Risk in the Surgical Patient. Journal of Clinical and Experimental Hematopathology.